Second Sight Medical Products: Jumps on resuming eye treatment device study

Vivani Medical

12/05/2021 12:32

** Vision-focused medical device maker's  EYES.O  shares
jump 20% to $6 premarket
    ** Co says study to test its device that helps people who
are blind see has resumed; it had been paused due to COVID-19
 urn:newsml:reuters.com:*:nBw9CHxvza
    ** Recent visual function results continue to show that a
majority of the participants benefit from its device, Orion -
EYES
    ** Co says all five patients that were tested were able to
locate a white square on a dark computer screen significantly
better with Orion System than without it
    ** The results from the trial are from a two-year study -
EYES
    ** The device provides artificial vision to people who are
blind due to a wide range of causes, including glaucoma,
diabetic retinopathy, optic nerve injury or disease, and eye
injury.
    ** Up to Tuesday's close, stock had more than doubled in
value this year

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))